Tomer Mark, MD

Tomer Mark, MD

Clinical Director of the Plasma Cell Disorders Program, Associate Professor of Medicine​

Research Focus:
Dr. Mark’s research focus has been on development of novel therapies for the care of multiple myeloma, including stem cell collection protocols and transplantation conditioning regimens. As a clinical trialist, he has been principal investigator on phase 1 trials of new compounds for use in refractory myeloma and stem cell transplantation.  He has also led phase 2 and 3 studies designed to maximize treatment efficacy in newly diagnosed and relapsed myeloma. As every myeloma is genetically distinct, his aim to develop and deliver personalized therapy for every patient based on scientific rationale.

years treating myeloma: 9

Number of Myeloma Patients Treated Annually: 200-500

Details & contact info

University of Colorado Cancer Center

Anschutz Medical Campus 1665 Aurora Court MS F754
Aurora, CO, United States, 80045

Phone: (720)-848-0414

View Full Physician Bio

View Website

Send a message to Tomer Mark, MD


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .